158 related articles for article (PubMed ID: 15917039)
21. Structural and sociocultural factors associated with cervical cancer screening among HIV-infected African American women in Alabama.
Williams M; Moneyham L; Kempf MC; Chamot E; Scarinci I
AIDS Patient Care STDS; 2015 Jan; 29(1):13-9. PubMed ID: 25514125
[TBL] [Abstract][Full Text] [Related]
22. Personal influencing factors associated with pap smear testing and cervical cancer.
Ackerson K; Pohl J; Low LK
Policy Polit Nurs Pract; 2008 Feb; 9(1):50-60. PubMed ID: 18492942
[TBL] [Abstract][Full Text] [Related]
23. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
24. Papanicolaou testing among women in the southern United States.
Peterson NB; Murff HJ; Cui Y; Hargreaves M; Fowke JH
J Womens Health (Larchmt); 2008; 17(6):939-46. PubMed ID: 18582173
[TBL] [Abstract][Full Text] [Related]
25. Adherence to cervical cancer screening guidelines for U.S. women aged 25-64: data from the 2005 Health Information National Trends Survey (HINTS).
Nelson W; Moser RP; Gaffey A; Waldron W
J Womens Health (Larchmt); 2009 Nov; 18(11):1759-68. PubMed ID: 19951209
[TBL] [Abstract][Full Text] [Related]
26. Papanicolaou test use among reproductive-age women at high risk for cervical cancer: analyses of the 1995 National Survey of Family Growth.
Hewitt M; Devesa S; Breen N
Am J Public Health; 2002 Apr; 92(4):666-9. PubMed ID: 11919069
[TBL] [Abstract][Full Text] [Related]
27. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
[TBL] [Abstract][Full Text] [Related]
28. Mammography, clinical breast exam, and pap testing: correlates of combined screening.
Pearlman DN; Rakowski W; Ehrich B
Am J Prev Med; 1996; 12(1):52-64. PubMed ID: 8776296
[TBL] [Abstract][Full Text] [Related]
29. Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care?
Wee CC; McCarthy EP; Davis RB; Phillips RS
Ann Intern Med; 2000 May; 132(9):697-704. PubMed ID: 10787362
[TBL] [Abstract][Full Text] [Related]
30. Pap smear receipt among Vietnamese immigrants: the importance of health care factors.
Taylor VM; Yasui Y; Nguyen TT; Woodall E; Do HH; Acorda E; Li L; Choe J; Jackson JC
Ethn Health; 2009 Dec; 14(6):575-89. PubMed ID: 19626504
[TBL] [Abstract][Full Text] [Related]
31. The frequency of Pap smear screening in the United States.
Sirovich BE; Welch HG
J Gen Intern Med; 2004 Mar; 19(3):243-50. PubMed ID: 15009779
[TBL] [Abstract][Full Text] [Related]
32. Cancer screening behaviors among U.S. women: breast cancer, 1987-1989, and cervical cancer, 1988-1989.
Ackermann SP; Brackbill RM; Bewerse BA; Cheal NE; Sanderson LM
MMWR CDC Surveill Summ; 1992 Apr; 41(2):17-25. PubMed ID: 1594013
[TBL] [Abstract][Full Text] [Related]
33. Pap smear screening among urban Southwestern American Indian women.
Risendal B; DeZapien J; Fowler B; Papenfuss M; Giuliano A
Prev Med; 1999 Dec; 29(6 Pt 1):510-8. PubMed ID: 10600432
[TBL] [Abstract][Full Text] [Related]
34. Using the health belief model to assess beliefs and behaviors regarding cervical cancer screening among Saudi women: a cross-sectional observational study.
Aldohaian AI; Alshammari SA; Arafah DM
BMC Womens Health; 2019 Jan; 19(1):6. PubMed ID: 30621680
[TBL] [Abstract][Full Text] [Related]
35. Demographics, self-efficacy, benefits/barriers, stages of adopting pap testing among Korean American women.
Tung WC; Granner M; Lu M; Sohn J
J Obstet Gynaecol; 2019 May; 39(4):510-515. PubMed ID: 30773963
[TBL] [Abstract][Full Text] [Related]
36. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States).
Benard VB; Lee NC; Piper M; Richardson L
Cancer Causes Control; 2001 Jan; 12(1):61-8. PubMed ID: 11227926
[TBL] [Abstract][Full Text] [Related]
37. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
38. Cancer screening in women: body mass index and adherence to physician recommendations.
Ferrante JM; Chen PH; Crabtree BF; Wartenberg D
Am J Prev Med; 2007 Jun; 32(6):525-31. PubMed ID: 17533069
[TBL] [Abstract][Full Text] [Related]
39. Papanicolaou smear screening of women with intellectual disabilities: a cross-sectional survey in Taiwan.
Lin LP; Lin JD; Sung CL; Liu TW; Liu YL; Chen LM; Chu CM
Res Dev Disabil; 2010; 31(2):403-9. PubMed ID: 19897337
[TBL] [Abstract][Full Text] [Related]
40. Health education to increase screening for cervical cancer among Lumbee Indian women in North Carolina.
Dignan MB; Michielutte R; Wells HB; Sharp P; Blinson K; Case LD; Bell R; Konen J; Davis S; McQuellon RP
Health Educ Res; 1998 Dec; 13(4):545-56. PubMed ID: 10345905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
